Robert Lorne Hopfner, Director, 10% Owner at Evommune, Inc. (EVMN), bought 1,000 shares at $17.35 ($17K) on 2025-12-19, disclosed to the SEC on 2025-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |
| INZY | BUY | 2022-04-20 | $3.9M | — | Filing → |